Publications
- Induction of tolerance and immunity by dendritic cells: Mechanisms and clinical applications2019 | Second Faculty of Medicine
- Phase I/II trial of dendritic cell-based active cellular immunotherapy with DCVAC/PCa in patients with rising PSA after primary prostatectomy or salvage radiotherapy for the treatment of prostate cancer2018 | First Faculty of Medicine, Second Faculty of Medicine
- Trial Watch: Toll-like receptor agonists in cancer immunotherapy2018 | Second Faculty of Medicine
- Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors2018 | Second Faculty of Medicine
- Chapter Three - Rationale for the Combination of Dendritic Cell-Based Vaccination Approaches With Chemotherapy Agents2017 | Second Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Dendritic cells pulsed with tumor cells killed by high hydrostatic pressure inhibit prostate tumor growth in TRAMP mice2017 | Second Faculty of Medicine
- Trial watch: Immune checkpoint blockers for cancer therapy2017 | Second Faculty of Medicine
- Trial Watch: Immunostimulation with Toll-like receptor agonists in cancer therapy2016 | Second Faculty of Medicine
- Dendritic cells pulsed with tumor cells killed by high hydrostatic pressure induce strong immune responses and display therapeutic effects both in murine TC-1 and TRAMP-C2 tumors when combined with docetaxel chemotherapy2016 | Second Faculty of Medicine
- Trial Watch: Immunotherapy plus radiation therapy for oncological indications2016 | Second Faculty of Medicine
Loading network view...